Abstract: Plant-derived medicines are projected to expand at a compound annual growth rate (CAGR) of 9% from 2021 to 2028, having already seen growth exceeding 9.0% in recent years fueled by a strong focus on preventative health care and nutritional medicines. India presents a unique opportunity to satisfy the rising demand, thanks to its rich natural biodiversity, featuring over 50,000 plant species and the advantage of low-cost production. The worldwide market for the Asia Pacific region holds more than 31% of this market share and is anticipated to maintain this leadership.
DownloadAbstract: Insulin, the blood sugar controlling peptide hormone, requires to be supplemented to diabetics intravenously to maintain healthy glucose levels. While the manufacturing of insulin and its analogs have been successfully achieved by many, the storage of the recombinant drug in its viable form at higher temperatures is a matter of constant concern.
Download